Dipyridamole
Administration
- Type: Antiplatelet
- Dosage Forms: Tablet 25mg, 50mg, 75mg; INJ
- Routes of Administration: Oral, IV
- Common Trade Names: Persantine
Adult Dosing
Cardiac Stress Testing
- 0.142 mg/kg/min IV x4min
Thromboembolism prevention adjunct for cardiac valve
- 75-100 mg PO qid
Thromboembolism prevention
- 50=100 mg PO qid
Angina prophylaxis
- 50 mg PO tid
Pediatric Dosing
Thromboembolism prevention adjunct for cardiac valve
Special Populations
Pregnancy Rating
- Caution advised during pregnancy
- Risk of increased maternal bleeding during delivery
Lactation risk
- Caution advised while breastfeeding
Renal Dosing
- Adult: No adjustment
- Pediatric: No adjustment
Hepatic Dosing
- Adult: Not defined
- Pediatric: Not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hypotension
- Bronchospasm, IV use
- Myocardial infarction, IV use
- Arrhythmia, IV use
Common
- Angina exacerbation
- Dizziness, Hypotension, Nausea, Headache
- Flushing, Rash
- Vomiting, Diarrhea, Abdominal pain
Pharmacology
- Half-life: 10 hours
- Metabolism: Liver
- Excretion: Bile
Mechanism of Action
- Inhibits platelet adenosine uptake, reducing platelet aggregation
- Augments cGMP production, dilating coronary arteries